Mechanisms of oral epigenetic reprogramming in tumorviral pathogenesis
口腔表观遗传重编程在肿瘤病毒发病机制中的机制
基本信息
- 批准号:8730747
- 负责人:
- 金额:$ 28.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-23 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS related cancerAIDS/HIV problemAcetylationAcquired Immunodeficiency SyndromeAffectAmericanAntiviral AgentsAntiviral ResponseArchivesAutoimmunityBacterial InfectionsBacteriologyBindingCell LineCell physiologyCellsChIP-seqChromatinComputer AnalysisDNADNA Modification ProcessDNA Polymerase IIData AnalysesDiseaseDisease ProgressionElementsEnzymesEpigenetic ProcessEpithelialEpithelial CellsEventExposure toGene ExpressionGenetic TranscriptionGoalsHIVHairy LeukoplakiaHerpesviridaeHistone DeacetylaseHistone H3HistonesHuman Herpesvirus 4Human PapillomavirusImmune responseImmunoblottingImmunoprecipitationIn VitroIndividualInterferonsKaposi SarcomaKnowledgeLatent VirusLearningLifeLiquid substanceLymphomaLyticMAPK11 geneMAPK14 geneMalignant NeoplasmsMediatingMethodsMethylationModificationMolecularMorbidity - disease rateMouth DiseasesOncogene ProteinsOncogenesOnset of illnessOralOral ManifestationsOral MedicineOral cavityOxidative StressOxidative Stress PathwayPapillomaPathogenesisPatientsPeriodontal DiseasesPeriodontal InfectionPeriodontitisPorphyromonas gingivalisPositioning AttributeProcessRegulationSiteSpecimenSquamous cell carcinomaStreptococcus sanguisTestingTranscriptTransplantationTreatment outcomeViralViral GenesViral GenomeViral Load resultViral PathogenesisVirusWorkbiobankbisulfiteburden of illnesschromatin modificationdata integrationepigenomeepigenomicsimmunosuppressedimprovedin vivoinhibitor/antagonistinsightmicrobiomeoral bacteriaoral cavity epitheliumoral pathogenoral wartpathogenpromoterpublic health relevancereactivation from latencyresponsetranscriptome sequencingtranslational approachtranslational studytumorigenesisvirology
项目摘要
DESCRIPTION (provided by applicant): Our increased understanding of the complexity of the microbiome has revealed great potential for pathogenic consequences. The effects of these interactions may be best revealed in further study of the oral cavity. The oral disease burden is exacerbated by activation of opportunistic tumorviruses resulting in oral morbidity and malignancy. Accumulating evidence suggests that epigenetic modifications are at the core of tumorviral pathogenesis modulating 1) host antiviral response and 2) viral reactivation, replication and expression of viral oncoproteins. DNA tumorviruses replicate in oral epithelia and are shed in oral fluids, inferring that replication and reactivation from latency are ongoing. A fundamental question is lack of knowledge regarding the latent to lytic transition in vivo. Why are
these viruses so successful in the mouth? We suggest that certain oral bacteria act as environmental triggers that allow for oral epigenetic reprogramming. We now have compelling evidence that oral bacterial products deregulate chromatin modifying enzymes, activate histone marks H3Ac and H4Ac, modify tumorviral promoters, and enhance viral gene expression associated with reactivation and oncogenesis in a species specific manner. Further, these bacterial products diminished the HDAC-associated antiviral interferon response. Collectively, these findings led us to hypothesize that within DNA tumorvirus infected cells, oral bacterial products alter the epigenetic landscape to enhance viral replication and alter cellular innate immune responses in the oral cavity. To test this hypothesis, we will focus on the identification of epigenetic elements central to bacterial modulation of early events in tumorviral pathogenesis. The study goals are to determine: (1) how the common oral pathogen P. gingivalis facilitates viral chromatin modifications critical to reactivation and oncogene expression (SA1 in vitro) (2) modification of host chromatin and gene expression central to the antiviral response (SA2 in vitro) and (3) in vivo correlates of active tumorviral chromatin and concurrent oral bacterial infections (SA3 in vivo). We will employ both standard and modern molecular methods, such as RNA-seq and ChIP-seq, together with targeted inhibition of epigenetic cellular processes to discern the mechanisms of viral chromatin regulation in Pg treated cells. We are uniquely positioned to accomplish these studies at UNC with leading expertise in epigenetics, oral medicine, virology, bacteriology, and computational analysis.
描述(由申请人提供):我们对微生物组的复杂性的增强理解揭示了致病后果的巨大潜力。这些相互作用的影响可以在进一步研究口腔中得到最好的揭示。通过激活机会性肿瘤病毒导致口腔发病和恶性肿瘤,口腔疾病负担加剧了。积累的证据表明,表观遗传修饰是调节肿瘤病毒发病机理的核心1)宿主抗病毒反应和2)病毒癌蛋白的病毒重新激活,复制和表达。 DNA肿瘤病毒在口服上皮中复制,并在口腔液中脱落,从而推断出潜伏期的复制和重新激活正在进行中。一个基本问题是缺乏关于体内裂解过渡的潜在的知识。为什么是
这些病毒在口中如此成功?我们建议某些口腔细菌充当环境触发器,可以进行口腔表观遗传重编程。现在,我们有令人信服的证据表明,口服细菌产物会导致染色质修饰酶,激活组蛋白标记H3AC和H4AC,修饰肿瘤病毒启动子,并以物种特异性方式增强与重新激活和肿瘤发生相关的病毒基因表达。此外,这些细菌产物减少了与HDAC相关的抗病毒干扰素反应。总的来说,这些发现使我们假设在DNA肿瘤感染细胞中,口腔细菌产物改变了表观遗传景观,以增强病毒复制并改变口腔中的细胞先天性免疫反应。为了检验这一假设,我们将重点关注鉴定肿瘤病毒发病机理中早期事件的细菌调节中心的表观遗传元件。 The study goals are to determine: (1) how the common oral pathogen P. gingivalis facilitates viral chromatin modifications critical to reactivation and oncogene expression (SA1 in vitro) (2) modification of host chromatin and gene expression central to the antiviral response (SA2 in vitro) and (3) in vivo correlates of active tumorviral chromatin and concurrent oral bacterial infections (SA3 in体内)。我们将同时采用标准和现代分子方法,例如RNA-Seq和ChIP-Seq,以及对表观遗传细胞过程的有针对性抑制,以辨别PG处理过的细胞中病毒染色质调节的机制。我们在UNC上具有领先的表观遗传学,口腔医学,病毒学,细菌学和计算分析方面的领先专业知识,可以在UNC上完成这些研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer Y Webster-Cyriaque其他文献
Jennifer Y Webster-Cyriaque的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer Y Webster-Cyriaque', 18)}}的其他基金
HERPESVIRUSES IN AIDS ASSOCIATED ORAL DISEASE
艾滋病相关口腔疾病中的疱疹病毒
- 批准号:
6379699 - 财政年份:2000
- 资助金额:
$ 28.61万 - 项目类别:
HERPESVIRUSES IN AIDS ASSOCIATED ORAL DISEASE
艾滋病相关口腔疾病中的疱疹病毒
- 批准号:
6896047 - 财政年份:2000
- 资助金额:
$ 28.61万 - 项目类别:
HERPESVIRUSES IN AIDS ASSOCIATED ORAL DISEASE
艾滋病相关口腔疾病中的疱疹病毒
- 批准号:
6147659 - 财政年份:2000
- 资助金额:
$ 28.61万 - 项目类别:
HERPESVIRUSES IN AIDS ASSOCIATED ORAL DISEASE
艾滋病相关口腔疾病中的疱疹病毒
- 批准号:
6615645 - 财政年份:2000
- 资助金额:
$ 28.61万 - 项目类别:
相似海外基金
Harnessing Stem-Like CD8 T Cells for Immunotherapies to Eradicate HIV Reservoirs
利用干细胞样 CD8 T 细胞进行免疫疗法来根除 HIV 病毒库
- 批准号:
10050054 - 财政年份:2021
- 资助金额:
$ 28.61万 - 项目类别:
Harnessing Stem-Like CD8 T Cells for Immunotherapies to Eradicate HIV Reservoirs
利用干细胞样 CD8 T 细胞进行免疫疗法来根除 HIV 病毒库
- 批准号:
10447569 - 财政年份:2021
- 资助金额:
$ 28.61万 - 项目类别:
Regulation of cyst formation in the AIDS opportunistic pathogen Toxoplasma
艾滋病机会病原体弓形虫包囊形成的调节
- 批准号:
10401525 - 财政年份:2021
- 资助金额:
$ 28.61万 - 项目类别:
Targeting lysine methylation for latency reversal in HIV-infected drug users
靶向赖氨酸甲基化以逆转感染艾滋病毒的吸毒者的潜伏期
- 批准号:
9236043 - 财政年份:2016
- 资助金额:
$ 28.61万 - 项目类别:
Cocaine in the Neuropathogenesis of HIV infection: Role of HDAC2
可卡因在 HIV 感染的神经发病机制中:HDAC2 的作用
- 批准号:
8410634 - 财政年份:2013
- 资助金额:
$ 28.61万 - 项目类别: